HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer
Clinical trial NCT07587034 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07587034
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-12-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.